Extraordinary standard: New protein could spur biopharmaceutical innovation

Go to article

Posted by on July 28, 2016 2:53 pm
Tags:
Categories: health

The universally available ‘public’ mAb will allow better assessment of existing analytical methods and potentially faster adoption of new technologies.

Leave a Reply

Your email address will not be published. Required fields are marked *

< Buzz Post home